Aurora Cannabis Inc T.ACB

Alternate Symbol(s): T.ACB.WS.U | ACB

Healthcare Cannabis

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.

TSX:ACB - Post by User

Aurora Cannabis Inc

Bullboard Posts

Comment by BobTBuilderon Nov 15, 2017 7:38am

513 Views

Post# 26965969

RE:RE:The Cannimed news is not well recieved in Frankfurt

TheRaj wrote:
If Cannimed accepts this 4.5 ACB share for every 1 CMED share then that will right away dilute ACB with an extra 102 million shares, which would make (at this moment) 1 ACB share worth $5.13/sh, instead of the now $6.41/sh ... I can see why Aurora is going down on the Frankfurt exchange

SHOW ME WHERE IT SAYS THEY WILL GET 4.5 SHARES OF ACB FOR EACH CMED SHARE...

If they will be receiving 4.5 shares why did they also mention 3.74415 shares based on yesterday's close?

Don't you think that maybe the number of shares of ACB for each CMED share is dependent on the ACB share price? Considering the variable that is locked in is the price of CMED $24.

Bullboard Posts

Changing Europe’s dependency on HREE from China